869 filings
Page 11 of 44
8-K
DRRX
Durect Corp
23 Apr 20
Entry into a Material Definitive Agreement
5:29pm
10-K
2019 FY
DRRX
Durect Corp
Annual report
5 Mar 20
2:59pm
8-K
DRRX
Durect Corp
3 Mar 20
DURECT Corporation Announces Fourth Quarter and Full Year 2019 Financial Results and Update of Programs
4:15pm
SC 13G
Lion Point Capital, LP
14 Feb 20
Durect Corp
3:19pm
SC 13G/A
Bleichroeder LP
12 Feb 20
Durect Corp
4:22pm
4
Bleichroeder LP
6 Feb 20
Change in insider ownership
6:10pm
4
Michael Arenberg
23 Jan 20
DURECT / Michael Arenberg ownership change
8:59pm
4
Joice Judy R
23 Jan 20
DURECT / Judy R Joice ownership change
8:58pm
4
James E Brown
23 Jan 20
DURECT / JAMES E BROWN ownership change
8:45pm
8-K
DRRX
Durect Corp
23 Jan 20
Departure of Directors or Certain Officers
4:30pm
SC 13G/A
DRRX
Durect Corp
23 Jan 20
Durect Corp
2:28pm
8-K
DRRX
Durect Corp
17 Jan 20
Other Events
2:34pm
8-K
DRRX
Durect Corp
6 Jan 20
Entry into a Material Definitive Agreement
8:16am
8-K
DRRX
Durect Corp
2 Jan 20
DURECT Corporation Announces Top-Line Results from Phase 2a Clinical Trial in Patients with Psoriasis
1:30pm
8-K
DRRX
Durect Corp
12 Nov 19
Other Events
5:06pm
10-Q
2019 Q3
DRRX
Durect Corp
Quarterly report
5 Nov 19
3:35pm
8-K
DRRX
Durect Corp
4 Nov 19
DURECT Corporation Announces Third Quarter 2019 Financial Results and Update of Programs
4:15pm
8-K
DRRX
Durect Corp
21 Oct 19
DURECT Announces DUR-928 Phase 2a Alcoholic Hepatitis Study Results Selected for Late-Breaking Oral Presentation at The Liver MeetingĀ® 2019
12:59pm
8-K
DRRX
Durect Corp
7 Oct 19
Other Events
3:30pm
8-K
DRRX
Durect Corp
2 Oct 19
DURECT Announces FDA Advisory Committee Meeting to Review POSIMIRĀ® for the Treatment of Post-Surgical Pain
3:30pm